Squarepoint’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $869K | Sell |
3,872
-110,285
| -97% | -$27.5M | ﹤0.01% | 2902 |
|
|
2025
Q4 | $27.5M | Sell |
114,157
-135,438
| -54% | -$34.6M | 0.03% | 603 |
|
|
2025
Q3 | $68.3M | Sell |
249,595
-296,773
| -54% | -$81.1M | 0.07% | 320 |
|
|
2025
Q2 | $141M | Buy |
546,368
+311,536
| +133% | +$74.3M | 0.15% | 136 |
|
|
2025
Q1 | $52.6M | Buy |
234,832
+230,887
| +5,853% | +$53.9M | 0.06% | 334 |
|
|
2024
Q4 | $902K | Sell |
3,945
-12
| -0.3% | -$2.89K | ﹤0.01% | 3157 |
|
|
2024
Q3 | $966K | Sell |
3,957
-24
| -0.6% | -$5.36K | ﹤0.01% | 2633 |
|
|
2024
Q2 | $762K | Sell |
3,981
-8
| -0.2% | -$1.62K | ﹤0.01% | 2758 |
|
|
2024
Q1 | $790K | Buy |
3,989
+4
| +0.1% | +$733 | ﹤0.01% | 2751 |
|
|
2023
Q4 | $686K | Sell |
3,985
-70,791
| -95% | -$10.9M | ﹤0.01% | 2786 |
|
|
2023
Q3 | $11.1M | Sell |
74,776
-44,126
| -37% | -$7.98M | 0.03% | 754 |
|
|
2023
Q2 | $26M | Buy |
118,902
+50,021
| +73% | +$11.1M | 0.08% | 285 |
|
|
2023
Q1 | $15.1M | Buy |
68,881
+17,245
| +33% | +$3.74M | 0.06% | 383 |
|
|
2022
Q4 | $10.7M | Buy |
+51,636
| New | +$11.3M | 0.04% | 469 |
|
|
2022
Q1 | – | Sell |
-54,655
| Closed | -$14.2M | – | 3409 |
|
|
2021
Q4 | $14.2M | Buy |
54,655
+22,342
| +69% | +$5.8M | 0.04% | 405 |
|
|
2021
Q3 | $8.52M | Buy |
32,313
+30,198
| +1,428% | +$8.26M | 0.02% | 562 |
|
|
2021
Q2 | $521K | Sell |
2,115
-25,711
| -92% | -$5.41M | ﹤0.01% | 2098 |
|
|
2021
Q1 | $5.4M | Buy |
27,826
+12,548
| +82% | +$2.52M | 0.03% | 596 |
|
|
2020
Q4 | $3.25M | Sell |
15,278
-14,559
| -49% | -$2.9M | 0.02% | 670 |
|
|
2020
Q3 | $5.12M | Buy |
+29,837
| New | +$5.51M | 0.07% | 343 |
|
|
2020
Q1 | – | Sell |
-4,389
| Closed | -$680K | – | 2405 |
|
|
2019
Q4 | $680K | Sell |
4,389
-17,495
| -80% | -$2.52M | ﹤0.01% | 1579 |
|
|
2019
Q3 | $2.96M | Buy |
21,884
+18,588
| +564% | +$2.44M | 0.03% | 667 |
|
|
2019
Q2 | $402K | Sell |
3,296
-16,484
| -83% | -$1.83M | ﹤0.01% | 1780 |
|
|
2019
Q1 | $2.06M | Buy |
+19,780
| New | +$2.04M | 0.02% | 760 |
|
|
2018
Q3 | – | Sell |
-37,135
| Closed | -$3.85M | – | 2186 |
|
|
2018
Q2 | $3.85M | Buy |
+37,135
| New | +$3.76M | 0.05% | 459 |
|
|
2017
Q4 | – | Sell |
-18,295
| Closed | -$1.41M | – | 2308 |
|
|
2017
Q3 | $1.41M | Buy |
+18,295
| New | +$1.4M | 0.03% | 609 |
|
|
2016
Q4 | – | Sell |
-23,290
| Closed | -$1.51M | – | 1900 |
|
|
2016
Q3 | $1.51M | Buy |
23,290
+12,243
| +111% | +$815K | 0.1% | 237 |
|
|
2016
Q2 | $699K | Sell |
11,047
-28,632
| -72% | -$1.69M | 0.04% | 467 |
|
|
2016
Q1 | $2.29M | Buy |
39,679
+18,717
| +89% | +$1.06M | 0.18% | 142 |
|
|
2015
Q4 | $1.13M | Buy |
+20,962
| New | +$1.18M | 0.12% | 236 |
|
Other funds holding RMD
VCM
VPM
DAM
Squarepoint's RMD Position: Q1 2026 in Review
Squarepoint reduced its ResMed (RMD) stake by 97% in Q1 2026, selling an estimated $27.5M and leaving 3,872 shares worth $869K. The position accounts for ﹤0.01% of the portfolio, ranked #2902.
Squarepoint first reported a position in RMD in Q4 2015 and has held it in 30 quarters since. The position peaked at $141M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Squarepoint held 3,872 shares of ResMed worth $869K as of Q1 2026.
- Squarepoint sold 110,285 ResMed shares in Q1 2026, an estimated $27.5M.
- ResMed made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2902 holding.
- Squarepoint first reported a position in ResMed in Q4 2015 and has held it in 30 quarters since.
- Squarepoint's ResMed position peaked at $141M in Q2 2025.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.